Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1989 Apr;86(8):2957–2960. doi: 10.1073/pnas.86.8.2957

Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel.

S E Guggino 1, D Lajeunesse 1, J A Wagner 1, S H Snyder 1
PMCID: PMC287039  PMID: 2468165

Abstract

An osteoblast calcium channel demonstrated by single channel recordings is associated with calcium antagonist receptor binding sites in osteoblast-like osteosarcoma cells. By using whole cell current recordings we now show that this channel is stimulated by the dihydropyridine calcium agonist drug BAY K 8644. A physiological relevance of these channels is apparent from the stereoselective, potent inhibition of parathyroid hormone-stimulated calcium uptake into osteoblast-like cells in culture by desmethoxyverapamil, a phenylalkylamine calcium antagonist. Secretion by these cells of the bone matrix protein osteocalcin is stimulated by BAY K 8644 and blocked by desmethoxyverapamil and nitrendipine. Evidence for a role of this channel in bone remodeling in intact animals comes from enhanced bone resorption in fetal rat bones observed with BAY K 8644 and stereoselective, potent blockade of resorption by desmethoxyverapamil.

Full text

PDF
2957

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beresford J. N., Gallagher J. A., Poser J. W., Russell R. G. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res. 1984;5(5):229–234. doi: 10.1016/0221-8747(84)90064-x. [DOI] [PubMed] [Google Scholar]
  2. Bertolini D. R., Nedwin G. E., Bringman T. S., Smith D. D., Mundy G. R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986 Feb 6;319(6053):516–518. doi: 10.1038/319516a0. [DOI] [PubMed] [Google Scholar]
  3. Chase L. R., Aurbach G. D. The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro. J Biol Chem. 1970 Apr 10;245(7):1520–1526. [PubMed] [Google Scholar]
  4. Gerry R. H., Rauch B., Colvin R. A., Adler P. N., Messineo F. C. Verapamil interaction with the muscarinic receptor: stereoselectivity at two sites. Biochem Pharmacol. 1987 Sep 15;36(18):2951–2956. doi: 10.1016/0006-2952(87)90208-5. [DOI] [PubMed] [Google Scholar]
  5. Guggino S. E., Wagner J. A., Snowman A. M., Hester L. D., Sacktor B., Snyder S. H. Phenylalkylamine-sensitive calcium channels in osteoblast-like osteosarcoma cells. Characterization by ligand binding and single channel recordings. J Biol Chem. 1988 Jul 25;263(21):10155–10161. [PubMed] [Google Scholar]
  6. Gundberg C. M., Hauschka P. V., Lian J. B., Gallop P. M. Osteocalcin: isolation, characterization, and detection. Methods Enzymol. 1984;107:516–544. doi: 10.1016/0076-6879(84)07036-1. [DOI] [PubMed] [Google Scholar]
  7. Herrmann-Erlee M. P., Konijn T. M. Effect of parathyroid extract on cyclic AMP content of embryonic mouse calvaria. Nature. 1970 Jul 11;227(5254):177–178. doi: 10.1038/227177a0. [DOI] [PubMed] [Google Scholar]
  8. Herrmann-Erlee M. P., van der Meer J. M., Löwik C. W., van Leeuwen J. P., Boonekamp P. M. Different roles for calcium and cyclic AMP in the action of PTH: studies in bone explants and isolated bone cells. Bone. 1988;9(2):93–100. doi: 10.1016/8756-3282(88)90109-3. [DOI] [PubMed] [Google Scholar]
  9. Hess P., Lansman J. B., Tsien R. W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature. 1984 Oct 11;311(5986):538–544. doi: 10.1038/311538a0. [DOI] [PubMed] [Google Scholar]
  10. Ibbotson K. J., Twardzik D. R., D'Souza S. M., Hargreaves W. R., Todaro G. J., Mundy G. R. Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha. Science. 1985 May 24;228(4702):1007–1009. doi: 10.1126/science.3859011. [DOI] [PubMed] [Google Scholar]
  11. Insel P. A. Phenylalkylamines are promiscuous receptor blockers. Trends Pharmacol Sci. 1988 Jan;9(1):10–10. doi: 10.1016/0165-6147(88)90231-3. [DOI] [PubMed] [Google Scholar]
  12. Karliner J. S., Motulsky H. J., Dunlap J., Brown J. H., Insel P. A. Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium. J Cardiovasc Pharmacol. 1982 May-Jun;4(3):515–520. doi: 10.1097/00005344-198205000-00025. [DOI] [PubMed] [Google Scholar]
  13. Lerner U. H., Fredholm B. B., Ransjö M. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro. Biochem J. 1986 Dec 1;240(2):529–539. doi: 10.1042/bj2400529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Löwik C. W., van Leeuwen J. P., van der Meer J. M., van Zeeland J. K., Scheven B. A., Herrmann-Erlee M. P. A two-receptor model for the action of parathyroid hormone on osteoblasts: a role for intracellular free calcium and cAMP. Cell Calcium. 1985 Aug;6(4):311–326. doi: 10.1016/0143-4160(85)90002-8. [DOI] [PubMed] [Google Scholar]
  15. Majeska R. J., Rodan S. B., Rodan G. A. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology. 1980 Nov;107(5):1494–1503. doi: 10.1210/endo-107-5-1494. [DOI] [PubMed] [Google Scholar]
  16. Meikle M. C. Bone physiology. Hypercalcaemia of malignancy. Nature. 1988 Nov 24;336(6197):311–311. doi: 10.1038/336311a0. [DOI] [PubMed] [Google Scholar]
  17. Nowycky M. C., Fox A. P., Tsien R. W. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature. 1985 Aug 1;316(6027):440–443. doi: 10.1038/316440a0. [DOI] [PubMed] [Google Scholar]
  18. Partridge N. C., Alcorn D., Michelangeli V. P., Kemp B. E., Ryan G. B., Martin T. J. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology. 1981 Jan;108(1):213–219. doi: 10.1210/endo-108-1-213. [DOI] [PubMed] [Google Scholar]
  19. Price P. A., Baukol S. A. 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem. 1980 Dec 25;255(24):11660–11663. [PubMed] [Google Scholar]
  20. RAISZ L. G. BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. J Clin Invest. 1965 Jan;44:103–116. doi: 10.1172/JCI105117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Raisz L. G. Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med. 1988 Mar 31;318(13):818–828. doi: 10.1056/NEJM198803313181305. [DOI] [PubMed] [Google Scholar]
  22. Reynolds I. J., Snowman A. M., Snyder S. H. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines. J Pharmacol Exp Ther. 1986 Jun;237(3):731–738. [PubMed] [Google Scholar]
  23. Riggs B. L., Melton L. J., 3rd Involutional osteoporosis. N Engl J Med. 1986 Jun 26;314(26):1676–1686. doi: 10.1056/NEJM198606263142605. [DOI] [PubMed] [Google Scholar]
  24. Snyder S. H. Drug and neurotransmitter receptors in the brain. Science. 1984 Apr 6;224(4644):22–31. doi: 10.1126/science.6322304. [DOI] [PubMed] [Google Scholar]
  25. Wagner J. A., Guggino S. E., Reynolds I. J., Snowman A. M., Biswas A., Olivera B. M., Snyder S. H. Calcium antagonist receptors. Clinical and physiological relevance. Ann N Y Acad Sci. 1988;522:116–133. doi: 10.1111/j.1749-6632.1988.tb33349.x. [DOI] [PubMed] [Google Scholar]
  26. Yamaguchi D. T., Hahn T. J., Iida-Klein A., Kleeman C. R., Muallem S. Parathyroid hormone-activated calcium channels in an osteoblast-like clonal osteosarcoma cell line. cAMP-dependent and cAMP-independent calcium channels. J Biol Chem. 1987 Jun 5;262(16):7711–7718. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES